Biochemical and biophysical research communications · 2020
Preventive role of regular low-intensity exercise during adolescence in schizophrenia model mice with abnormal behaviors.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koizumi Hikaru, Hiraga Taichi, Oharomari Leandro K, Hata Toshiaki, Shima Takeru, Yook Jang Soo, Okamoto Masahiro, Mouri Akihiro, Nabeshima Toshitaka, Soya Hideaki
Аннотация
Schizophrenia is probably ascribed to perinatal neurodevelopmental deficits, and its onset might be affected by environmental factors. Hypofrontality with glutamatergic and dopaminergic neuronal dysfunction are known factors, but a way to mitigate abnormalities remains unfound. An early enriched environment such as a wheel running in rodents may contribute to the prevention, but its clinical applicability is very limited. From our studies, low-intensity exercise training (LET) based on physiological indices, such as lactate threshold, easily translates to humans and positively affects the brains. Hence, LET during adolescence may ameliorate abnormalities in neurodevelopment and prevent the development of schizophrenia. In the current study, LET prevented sensitization to phencyclidine (PCP) treatment, impairment of cognition, and affective behavioral abnormalities in an animal model of schizophrenia induced by prenatal PCP treatment. Further, LET increased dopamine turnover and attenuated the impairment of phosphorylation of ERK1/2 after exposure to a novel object in the prenatal PCP-treated mice. These results suggest that LET during adolescence completely improves schizophrenia-like abnormal behaviors associated with improved glutamate uptake and the dopamine-induced ERK1/2 signaling pathway in the PFC.
Предметные рубрики MeSH
3,4-Dihydroxyphenylacetic AcidAge FactorsAnimalsBehavior, AnimalDisease Models, AnimalDopamineExcitatory Amino Acid AntagonistsFemaleHomovanillic AcidMAP Kinase Signaling SystemMaleMiceMice, Inbred ICRPhencyclidinePhosphorylationPhysical Conditioning, AnimalPrefrontal CortexPregnancyPrenatal Exposure Delayed EffectsReceptors, N-Methyl-D-AspartateSchizophreniaSchizophrenic Psychology